1H NMR characterization of methacrylamide polymer conjugates with the anti-cancer drug doxorubicin

Magnetic Resonance in Chemistry

Volumn 35, Issue 1, 1997, Pages 2-8

  Pinciroli, V ^a   Rizzo, V ^a   Angelucci, F ^a   Tato M ^a   Vigevani, A ^a  

^a PFIZER INC   (United States)

Author keywords

1H NMR; D galactosamine; Doxorubicin; Drug targeting; NMR

Indexed keywords

CHAINS; DISEASES; MOLECULES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

1H NMR; ANTICANCER DRUG; D-GALACTOSAMINE; DOXORUBICIN; DRUG-TARGETING; H NMR SPECTROSCOPY; METHACRYLAMIDES; POLYMER CONJUGATE; PYRANOSE; SPECTRA'S;

GALACTOSAMINE;

EID: 0031540937     PISSN: 07491581     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-458X(199701)35:1<2::AID-OMR24>3.0.CO;2-D     Document Type: Article

References (11)

1. R. Duncan, Anti-Cancer Drugs 3, 175 (1992).
2. K. D. Widder and R. Green (Eds), Drugs and Enzyme Targeting. Part A. Methods in Enzymology, vol. 112, Section IV. Academic Press, Orlando (1985).
3. P. A. Vasey, R. Duncan, S. B. Kaye and J. Cassidy, in Abstracts of the 8th European Conference on Clinical Oncology, Paris, 1995, Abstract 929.
4. F. Arcamone Doxorubicin. Anticancer Antibiotics. Academic Press, New York (1981).
5. R. Duncan, H. C. Cable, J. B. Lloyd, P. Rejmanova and J. Kopecek, Makromol. Chem. 184, 1997 (1984).
6. R. Duncan, J. C. Hume, P. Kopecekova, K. Ulbrich, J. Strohlam and J. Kopacek, J. Controlled Release 10, 51 (1989).
7. R. Duncan, L. C. W. Seymour, L. Scarlett, J. B. Lloyd, P. Rejmanova and J. Kopecek, Biochim. Biophys. Acta 880, 62 (1986).
8. M. V. Pimm, A. C. Perkins, R. Duncan and K. Ulbrich, J. Drug Targeting 1, 125 (1993).
9. E. Configliacchi, G. Razzano, V. Rizzo and A. Vigevani, J. Pharm. Biomed. Anal. 15, 123 (1996).
10. K. Wüthrich, NMR of Proteins and Nucleic Acids. Wiley, New York (1986).
11. E. Breitmeier and W. Voelter, Carbon-13 NMR Spectroscopy. VCH, Weinheim (1987).